K Korro Bio, Inc.: directors' dealings · United States · SEC (Form 4) Explore the full directors' dealings record of Korro Bio, Inc., a listed issuer based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €157.8m. The latest transaction was reported on 2 June 2026 (Cession). Among the most active insiders: FORMELA JEAN FRANCOIS. The full history is accessible without an account.
€259,576
5 ops.
Sell Volume
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 2 June 2026
All Executives25 Thresholds0 Prospectus0 Other0
Declarations 25 total
▼ President and CEO · Executives · 29 May 2026
15,152 shares @ US$12.98 24.2% of flow Common Stock SEC:0001193125-26-252460:0
▼ Director · Executives · 28 May 2026
2,441 shares @ US$13.95 3.0% of flow Common Stock SEC:0001030575-26-000002:0
▼ Director · Executives · 28 May 2026
419 shares @ US$13.95 0.5% of flow Common Stock SEC:0001030575-26-000002:1
◆ President and CEO · Executives · 26 May 2026
50,000 shares @ US$12.33 75.8% of flow Common Stock SEC:0001193125-26-245491:0
◇ Chief Financial Officer · Executives · 11 Nov 2024
800 shares @ US$11.68 5.4% of flow Common Stock SEC:0000950170-24-125822:0
▼ Chief Financial Officer · Executives · 11 Nov 2024
800 shares @ US$70.00 32.5% of flow Common Stock SEC:0000950170-24-125822:1
◇ Chief Financial Officer · Executives · 17 Oct 2024
9,263 shares @ US$11.68 62.1% of flow Common Stock SEC:0000950170-24-115723:0
17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047686:0
Ideal exit: 17 Jan 2025 (T+270) 17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047682:0
Ideal exit: 17 Jan 2025 (T+270) 17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047685:0
Ideal exit: 17 Jan 2025 (T+270) ◆ Director · Executives · 22 Apr 2024
17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047684:0
17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047680:0
Ideal exit: 17 Jan 2025 (T+270) 17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047683:0
Ideal exit: 17 Jan 2025 (T+270) 17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047678:0
Ideal exit: 17 Jan 2025 (T+270) 17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047679:0
Ideal exit: 17 Jan 2025 (T+270) 17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047687:0
Ideal exit: 17 Jan 2025 (T+270) 17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0000950170-24-047681:0
Ideal exit: 17 Jan 2025 (T+270) 17,857 shares @ US$56.00 100.0% of flow Common Stock SEC:0001415889-24-011385:0
Ideal exit: 17 Jan 2025 (T+270) ◆ Director · Executives · 22 Apr 2024
17,857 shares @ US$56.00 96.5% of flow Common Stock SEC:0001415889-24-011388:0
▼ Director · Executives · 22 Nov 2023
110 shares @ US$35.9873 100.0% of flow Common Stock SEC:0000950170-23-066217:0
◇ Director · Executives · 3 Nov 2023
5,600 shares Common Stock SEC:0000950170-23-065866:0
◆ Director · Executives · 3 Nov 2023
942,075 shares Common Stock SEC:0000950170-23-060597:0
◆ Director · Executives · 3 Nov 2023
1,072,936 shares Common Stock SEC:0001209191-23-054637:0
◆ President and CEO · Executives · 3 Nov 2023
4,613 shares Common Stock SEC:0000950170-23-060606:0
◆ Director · Executives · 3 Nov 2023
35,114 shares Common Stock SEC:0000950170-23-060608:0